The immune inhibitory receptor LAIR-1 is highly expressed by plasmacytoid dendritic cells and acts complementary with NKp44 to control IFNα production

PLoS ONE

Volumn 5, Issue 11, 2010, Pages

  Bonaccorsi, Irene ^a   Cantoni, Claudia ^b,c   Carrega, Paolo ^c   Oliveri, Daniela ^a   Lui, Gabrielle ^c   Conte, Romana ^d   Navarra, Michele ^a   Cavaliere, Riccardo ^a   Traggiai, Elisabetta ^b,c   Gattorno, Marco ^b,c   Martini, Alberto ^b,c   Mingari, Maria Cristina ^b,d   Moretta, Alessandro ^b   Ferlazzo, Guido ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c G GASLINI INSTITUTE   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CELL RECEPTOR; INTERLEUKIN 3; LEUKOCYTE ASSOCIATED IMMUNOGLOBULIN LIKE RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; IMMUNOGLOBULIN RECEPTOR; LEUKOCYTE-ASSOCIATED IMMUNOGLOBULIN-LIKE RECEPTOR 1; NCR2 PROTEIN, HUMAN;

AMINO ACID SEQUENCE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD SAMPLING; CELL ISOLATION; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; PLASMACYTOID DENDRITIC CELL; PROTEIN CROSS LINKING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; BLOOD; CELL CULTURE; DENDRITIC CELL; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; GENETICS; LYMPHOID TISSUE; METABOLISM; NATURAL KILLER CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYSTEMIC LUPUS ERYTHEMATOSUS;

CELLS, CULTURED; DENDRITIC CELLS; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; INTERFERON-ALPHA; KILLER CELLS, NATURAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOID TISSUE; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; RECEPTORS, IMMUNOLOGIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78649785772     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015080     Document Type: Article

References (35)

1. Gilliet M, Cao W, Liu YJ (2008) Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 8: 594-606.
2. Sozzani S, Vermi W, Del Prete A, Facchetti F (2010) Trafficking properties of plasmacytoid dendritic cells in health and disease. Trends Immunol 31: 270-277.
3. Kadowaki N, Antonenko S, Liu YJ (2001) Distinct CpG DNA and polyinosinicpolycytidylic acid double-stranded RNA, respectively, stimulate CD11c2 type 2 dendritic cell precursors and CD11c + dendritic cells to produce type I IFN. J Immunol 166: 2291-2295.
4. Banchereau J, Pascual V (2006) Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25: 383-392.
5. Dzionek A, Sohma Y, Nagafune J, Cella M, Colonna M, et al. (2001) BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon alpha/beta induction. J Exp Med 194: 1823-1834.
6. Bave U, Magnusson M, Eloranta ML, Perers A, Alm GV, et al. (2003) Fc gamma RIIa is expressed on natural IFN-alpha-producing cells (plasmacytoid dendritic cells) and is required for the IFN-alpha production induced by apoptotic cells combined with lupus IgG. J Immunol 171: 3296-3302.
7. Blasius AL, Cella M, Maldonado J, Takai T, Colonna M (2006) Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood 107: 2474-2476.
8. Cao W, Rosen DB, Ito T, Bover L, Bao M, et al. (2006) Plasmacytoid dendritic cell-specific receptor ILT7-Fc epsilonRI gamma inhibits Toll-like receptorinduced interferon production. J Exp Med 203: 1399-1405.
9. Fanning SL, George TC, Feng D, Feldman SB, Megjugorac NJ, et al. (2006) Receptor cross-linking on human plasmacytoid dendritic cells leads to the regulation of IFN-alpha production. J Immunol 177: 5829-5839.
10. Cantoni C, Bottino C, Augugliaro R, Morelli L, Marcenaro E, et al. (1999) Molecular and functional characterization of IRp60, a member of the immunoglobulin superfamily that functions as an inhibitory receptor in human NK cells. Eur J Immunol 29: 3148-3159.
11. Ju X, Zenke M, Hart DN, Clark GJ (2008) CD300a/c regulate type I interferon and TNF-alpha secretion by human plasmacytoid dendritic cells stimulated with TLR7 and TLR9 ligands. Blood 112: 1184-1194.
12. Fuchs A, Cella M, Kondo T, Colonna M (2005) Paradoxic inhibition of human natural interferon-producing cells by the activating receptor NKp44. Blood 106: 2076-2082.
13. Vitale M, Bottino C, Sivori S, Sanseverino L, Castriconi R, et al. (1998) NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, isinvolved in non-major histocompatibility complex-restricted tumor cell lysis. J Exp Med 187: 2065-2072.
14. Cantoni C, Bottino C, Vitale M, Pessino A, Augugliaro R, et al. (1999) NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. J Exp Med 189: 787-796.
15. Campbell KS, Yusa S, Kikuchi-Maki A, Catina TL (2004) NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence. J Immunol 172: 899-906.
16. Poggi A, Pella N, Morelli L, Spada F, Revello V, et al. (1995) P40, a novel surface molecule involved in the regulation of the non-major histocompatibility complex-restricted cytolytic activity in humans. Eur J Immunol 25: 369-376.
17. Meyaard L, Adema GJ, Chang C, Woollatt E, Sutherland GR, et al. (1997) LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity 7: 283-290.
18. Meyaard L (2008) The inhibitory collagen receptor LAIR-1 (CD305). J Leukoc Biol 83: 799-803.
19. Poggi A, Tomasello E, Revello V, Nanni L, Costa P, et al. (1997) P40 molecule regulates NK cell activation mediated by NK receptors for HLA class I antigens and TCR-mediated triggering of T lymphocytes. Int Immunol 9: 1271-1279.
20. Meyaard L, Hurenkamp J, Clevers H, Lanier LL, Phillips JH (1999) Leukocyteassociated Ig-like receptor-1 functions as an inhibitory receptor on cytotoxic T cells. J Immunol 162: 5800-5804.
21. Merlo A, Tenca C, Fais F, Battini L, Ciccone E, et al. (2005) Inhibitory receptors CD85j, LAIR-1, and CD152 down-regulate immunoglobulin and cytokine production by human B lymphocytes. Clin Diagn Lab Immunol 12: 705-712.
22. Poggi A, Tomasello E, Ferrero E, Zocchi MR, Moretta L (1998) P40/LAIR-1 regulates the differentiation of peripheral blood precursors to dendritic cells induced by granulocyte-monocyte colony-stimulating factor. Eur J Immunol 28: 2086-2091.
23. Bave U, Alm GV, Ronnblom L (2000) The combination of apoptotic U937 cells and lupus IgG is a potent IFN-alpha inducer. J Immunol 165: 3519-3526.
24. Wu P, Wu J, Liu S, Han X, Lu J, et al. (2008) TLR9/TLR7-triggered downregulation of BDCA2 expression on human plasmacytoid dendritic cells from healthy individuals and lupus patients. Clin Immunol 129: 40-48.
25. Pascual V, Farkas L, Banchereau J (2006) Systemic lupus erythematosus: all roads lead to type I interferons. Curr Opin Immunol 18: 676-682.
26. Ronnblom L, Pascual V (2008) The innate immune system in SLE: type I interferons and dendritic cells. Lupus 17: 394-399.
27. Colonna M, Trinchieri G, Liu YJ (2004) Plasmacytoid dendritic cells in immunity. Nat Immunol 5: 1219-1226.
28. Albanesi C, Scarponi C, Pallotta S, Daniele R, Bosisio D, et al. (2009) Chemerin expression marks early psoriatic skin lesions and correlates with plasmacytoid dendritic cell recruitment. J Exp Med 206: 249-258.
29. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J (2001) Induction of dendritic cell differentiation by IFN-alpha in systemic lupus erythematosus. Science 294: 1540-1543.
30. van der Vuurst de Vries AR, Clevers H, Logtenberg T, Meyaard L (1999) Leukocyte-associated immunoglobulin-like receptor-1 (LAIR-1) is differentially expressed during human B cell differentiation and inhibits B cell receptormediated signaling. Eur J Immunol 29: 3160-3167.
31. Jansen CA, Cruijsen CW, de Ruiter T, Nanlohy N, Willems N, et al. (2007) Regulated expression of the inhibitory receptor LAIR-1 on human peripheral T cells during T cell activation and differentiation. Eur J Immunol 37: 914-924.
32. Vivier E, Nunes JA, Vely F (2004) Natural killer cell signaling pathways. Science 306: 1517-1519.
33. Pasquier B, Launay P, Kanamaru Y, Moura IC, Pfirsch S, et al. (2005) Identification of FcalphaRI as an inhibitory receptor that controls inflammation: dual role of FcRgamma ITAM. Immunity 22: 31-42.
34. Ferlazzo G, Pack M, Thomas D, Paludan C, Schmid D, et al. (2004) Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci U S A 101: 16606-16611.
35. Carrega P, Morandi B, Costa R, Frumento G, Forte G, et al. (2008) Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells. Cancer 112: 863-875.